ACUTE RESPIRATORY FAILURE SECONDARY NIVOLUMAB MYOSITIS
نویسندگان
چکیده
منابع مشابه
Myositis and acute respiratory infection.
formulation as blue-coloured, sweet-tasting tablets, and in the fact that it is prescribed for migraine, a relatively non-serious disease. Dixarit is probably regarded as a non-dangerous drug, being stored in places accessible to children, while, by contrast, the antihypertensive Catapres is treated with appropriate respect. We hope that this article will alert doctors prescribing Dixarit so th...
متن کاملA Case of Nivolumab-Induced Myositis
Introduction TheMay2016issueofTheOncologistsummarizesU.S.Foodand Drug Administration approval for nivolumab in non-small cell lung cancer [1]. In response, we present a case of nivolumabinducedmyositis, an unlisted side effect that has been reported only once previously. Nivolumab (Opdivo) is a monoclonal antibody classified as an immune modulator. It binds to programmed cell death-1 (PD-1) and...
متن کاملHyponatraemia secondary to nivolumab-induced primary adrenal failure
Checkpoint inhibitors, such as ipilimumab and pembrolizumab, have transformed the prognosis for patients with advanced malignant melanoma and squamous non-small-cell lung cancer, and their use will only expand as experience is gained in a variety of other malignancies, for instance, renal and lymphoma. As the use of checkpoint inhibitors increases, so too will the incidence of their unique side...
متن کاملInclusion body myositis as a cause of respiratory failure.
Inclusion body myositis (IBM) is a slowly progressive myopathy that has not been reported to affect respiratory muscles. It is often refractory to treatment and a muscle biopsy specimen is necessary for the diagnosis. This is a report of a patient with IBM who quickly progressed to respiratory muscle failure requiring intubation.
متن کاملHypoxemic Respiratory Failure from Acute Respiratory Distress Syndrome Secondary to Leptospirosis
Acute respiratory distress syndrome (ARDS), characterized by hypoxemic respiratory failure, is associated with a mortality of 30-50% and is precipitated by both direct and indirect pulmonary insults. Treatment is largely supportive, consisting of lung protective ventilation and thereby necessitating Intensive Care Unit (ICU) admission. The most common precipitant is community-acquired bacterial...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Chest
سال: 2020
ISSN: 0012-3692
DOI: 10.1016/j.chest.2020.08.856